Craft

PROBIOTEC

Stock Price

$22.8

2024-10-29

Market Capitalization

$92.5 M

2024-08-26

Revenue

$214 M

FY, 2023

PROBIOTEC Summary

Company Summary

Overview
PROBIOTEC is a manufacturer, marketer, and distributor of pharmaceuticals, complementary medicines, and specialty ingredients. Its products include solid dose tablets, liquids, creams, lotions, powders, sprays, and other products.
Type
Public
Status
Active
Founded
1997
HQ
Laverton North, AU | view all locations
Website
https://probiotec.com.au/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Alexander Beard, Non-Executive Director, Chairman

    • Jonathan Wenig, Non-Executive Director

      • Wesley Stringer, Executive Director, Chief Executive Officer

        LocationsView all

        2 locations detected

        • Laverton North, VIC HQ

          Australia

          83 Cherry Ln

        • Sydney, NSW

          Australia

          1 Gresham St

        PROBIOTEC Financials

        Summary Financials

        Revenue (H1, 2024)
        $114.0M
        Gross profit (H1, 2024)
        $33.8M
        Net income (H1, 2024)
        $3.1M
        Cash (H1, 2024)
        $12.8M
        EBIT (H1, 2024)
        $8.1M
        Enterprise value
        $126.0M

        Footer menu